On Tuesday, Mersana Therapeutics Inc (NASDAQ: MRSN) opened higher 3.04% from the last session, before settling in for the closing price of $2.30. Price fluctuations for MRSN have ranged from $1.22 to $6.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 12371.94% over the last five years. Company’s average yearly earnings per share was noted 60.21% at the time writing. With a float of $86.30 million, this company’s outstanding shares have now reached $122.87 million.
The firm has a total of 123 workers. Let’s measure their productivity. In terms of profitability, gross margin is 48.0%, operating margin of -228.07%, and the pretax margin is -212.99%.
Mersana Therapeutics Inc (MRSN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mersana Therapeutics Inc is 30.14%, while institutional ownership is 66.09%. The most recent insider transaction that took place on Oct 28 ’24, was worth 3,580. In this transaction SVP, Chief Development Officer of this company sold 1,884 shares at a rate of $1.90, taking the stock ownership to the 54,731 shares. Before that another transaction happened on Oct 28 ’24, when Company’s Officer proposed sale 1,884 for $2.04, making the entire transaction worth $3,843.
Mersana Therapeutics Inc (MRSN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 60.21% per share during the next fiscal year.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
Check out the current performance indicators for Mersana Therapeutics Inc (MRSN). In the past quarter, the stock posted a quick ratio of 2.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Analysing the last 5-days average volume posted by the [Mersana Therapeutics Inc, MRSN], we can find that recorded value of 1.19 million was lower than the volume posted last year of 1.59 million. As of the previous 9 days, the stock’s Stochastic %D was 81.56%. Additionally, its Average True Range was 0.23.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 71.43%, which indicates a significant increase from 49.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 119.18% in the past 14 days, which was higher than the 103.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.09, while its 200-day Moving Average is $2.64. Now, the first resistance to watch is $2.52. This is followed by the second major resistance level at $2.66. The third major resistance level sits at $2.79. If the price goes on to break the first support level at $2.25, it is likely to go to the next support level at $2.12. Now, if the price goes above the second support level, the third support stands at $1.98.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
There are currently 123,533K shares outstanding in the company with a market cap of 292.78 million. Presently, the company’s annual sales total 36,860 K according to its annual income of -171,670 K. Last quarter, the company’s sales amounted to 12,600 K and its income totaled -11,500 K.
